OpenLegislation

The Export Control (Amendment) Order 2012

S.I. 2012/929 · Made 23 March 2012

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Customs

Made 23rd March 2012

Laid before Parliament 26th March 2012

Coming into force 16th April 2012

The Secretary of State, in exercise of the powers conferred by sections 1 and 5 of the Export Control Act 2002f1, makes the following Order.

Annotations to the whole text

Footnotes

f1

2002 c. 28.

Contents

  1. 1Citation and commencement
  2. 2Revocation
  3. 3Amendments to the Export Control Order 2008
  4. Signature
  5. Explanatory note

1Citation and commencement

This Order may be cited as the Export Control (Amendment) Order 2012 and comes into force on 16th April 2012.

2Revocation

The Export Control (Amendment) (No. 3) Order 2011f1 is revoked.

3Amendments to the Export Control Order 2008

(1)

The Export Control Order 2008f1 is amended as follows.

(2)

After article 4 insert —

“Movement of certain medicinal products to the United States of America

4A.
(1)

Subject to articles 17 and 26, no person shall export a human or veterinary medicinal product containing the active ingredient pancuronium bromide where—

(a)

the product is in a form suitable for injection or for preparation of an injection; and

(b)

paragraph (2) or (3) applies.

(2)

This paragraph applies where the destination of the product is the United States of America.

(3)

This paragraph applies where the destination is not the United States of America but the exporter knows that the final destination of the product is the United States of  America.”.

(3)

In article 17 (transit or transhipment exception), in paragraph (1) after “4,” insert “4A,”.

(4)

In article 41 (application of CEMA in respect of offences), in each of paragraphs (1)(a)(i) and (2)(a) after “4,” insert “4A,”.

Signature

David Willetts

Minister of State for Universities and Science

Department for Business, Innovation and Skills

23rd March 2012

Explanatory note

(This note is not part of the Order)

This Order amends the Export Control Order 2008 (S.I. 2008/3231) to insert article 4A to prohibit the export of human and veterinary medicinal products containing pancuronium bromide. The prohibition only applies to the export of these products where they are in a form suitable for injection or for preparation of an injection and the final destination is the United States of America.

It also revokes the Export Control (Amendment) (No.3) Order 2011 (S.I. 2011/1127) which is spent.

A regulatory impact assessment has not been prepared for this instrument as it has no or minimal impact on business, charities or voluntary bodies. An Explanatory Memorandum is published alongside the instrument on www.legislation.gov.uk.